Mesenchymal stem cell treatment for COVID-19

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has caused a global pandemic since late 2019 that resulted in more than 360 million population infection. Among them, less than 7% of infected individuals develop severe or critical illness. Mass vaccination has been carried out,...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Ruonan, Feng, Zhiqian, Wang, Fu-Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8907937/
https://www.ncbi.nlm.nih.gov/pubmed/35279630
http://dx.doi.org/10.1016/j.ebiom.2022.103920

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8907937/
https://www.ncbi.nlm.nih.gov/pubmed/35279630
http://dx.doi.org/10.1016/j.ebiom.2022.103920

Ejemplares similares